Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

BACKGROUND: Etanercept, infliximab and adalimumab are licensed in the UK for the treatment of active and progressive psoriatic arthritis (PsA) in adults who have an inadequate response to standard treatment. OBJECTIVE: To determine the clinical effectiveness, safety and cost-effectiveness of these b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Rodgers, M, Epstein, D, Bojke, L, Yang, H, Craig, D, Fonseca, T, Myers, L, Bruce, I, Chalmers, R, Bujkiewicz, S, Lai, M, Cooper, N, Abrams, K, Spiegelhalter, D, Sutton, A, Sculpher, M, Woolacott, N
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781419/
https://ncbi.nlm.nih.gov/pubmed/21333232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta15100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados